These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Toxic epidermal necrolysis due to use of sulfamide (Lyell syndrome)]. Cetković DK, Popović A, Sertić A. Vojnosanit Pregl; 1968 Nov; 25(11):583-5. PubMed ID: 5193794 [No Abstract] [Full Text] [Related]
24. Toxic epidermal necrolysis (Lyell syndrome) and its medico-legal implications. Timperman J, Verbauwhede W. Z Rechtsmed; 1972 Nov 28; 71(2):139-44. PubMed ID: 4656068 [No Abstract] [Full Text] [Related]
25. [Toxic epidermal necrolysis due to lamotrigine]. Beerhorst K, Renier WO. Ned Tijdschr Geneeskd; 2003 Jun 07; 147(23):1128-31. PubMed ID: 12822524 [Abstract] [Full Text] [Related]
26. Toxic epidermal necrolysis: an approach to management using cryopreserved allograft skin. Birchall N, Langdon R, Cuono C, McGuire J. J Am Acad Dermatol; 1987 Feb 07; 16(2 Pt 1):368-72. PubMed ID: 3546416 [Abstract] [Full Text] [Related]
37. Lyell's disease, the Stevens-Johnson Syndrome, and exfoliative dermatitis. Ostler HB, Conant MA, Groundwater J. Trans Am Acad Ophthalmol Otolaryngol; 1970 Feb 07; 74(6):1254-65. PubMed ID: 4250164 [No Abstract] [Full Text] [Related]
38. [Toxic epidermal necrolysis after the use of intermediate dose of cytosine arabinoside]. Figueiredo MS, Yamamoto M, Kerbauy J. Rev Assoc Med Bras (1992); 1998 Feb 07; 44(1):53-5. PubMed ID: 9629704 [Abstract] [Full Text] [Related]